Trials / Not Yet Recruiting
Not Yet RecruitingNCT07271134
Short-term Observation on the Clinical Application Effect of Astra Tech Implant EV Short Implants for Maxillary Sinus Elevation
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- Sponsor
- Linhu Wang · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Short-term comparison of clinical application effects of Astra OsseoSpeed EV short implants and conventional implants for maxillary sinus elevation
Detailed description
1. If the survival rate, marginal bone resorption , complications and patient satisfaction of the short implant group are comparable or better than those of the conventional implant group, then short implants can be regarded as an effective treatment option for insufficient alveolar bone in the posterior teeth area. Thus, in clinical practice, the investigators can utilize short implants combined with transcrestal sinus floor elevation, or even implant short implants to help patients with certain insufficient maxillary bone complete implant restoration without resorting to more complex, costly and more invasive external elevation surgery to increase the length of posterior teeth implants in the maxillary region. 2. If it is found that the short implant group has a higher incidence of complications or a lower long-term survival rate, further exploration of its indications and optimization of surgical strategies is required.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | short implants (L=6.3mm) | Short-term clinical outcome of Astra OsseoSpeed EV short implants (L=6.3mm) for transcrestal sinus floor elevation |
| PROCEDURE | short implants (L=8mm) | Short-term clinical outcome of Astra OsseoSpeed EV short implants (L=8mm) for transcrestal sinus floor elevation |
| DEVICE | conventional implants (L=9mm) | conventional implants (L=9mm) in the posterior maxillary region for dental restoration |
Timeline
- Start date
- 2025-12-10
- Primary completion
- 2027-06-30
- Completion
- 2028-07-30
- First posted
- 2025-12-09
- Last updated
- 2025-12-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07271134. Inclusion in this directory is not an endorsement.